Search Icon
KRON Archived Articles

Kronos Bio's Strategic Shift Amid Clinical Setbacks

Published on November 28, 2024

Kronos Bio, Inc. (NASDAQ:KRON): Targeting Deregulated Transcription in Cancer with Promising Pipeline

Published on September 24, 2024